i
There has been rapid progress in the development of Left Ventricular Assist Devices (LVAD) technology and Artificial Hearts (AH). Due to the nature of the target population, there is limited documentation from randomized clinical trials. The current recommendations reflect this limited evidence. There is therefore no consensus concerning Left Ventricular Assist Devices (LVAD) indications or the most appropriate patient population. Left Ventricular Assist Devices (LVAD) technology is likely to undergo substantial improvement in the near future, and the recommendations will need revision accordingly.

Class of recommendation IIa, level of evidence C
Current indications for Left Ventricular Assist Devices (LVAD) and Artificial Hearts (AH) include bridging to transplantation and managing patients with acute, severe myocarditis.

Class of recommendation IIb, level of evidence C
Although experience is limited, these devices may be considered for long-term use when no definitive procedure is planned.